The mechanisms that control proliferation and differentiation of embryonic lung mesenchyme are largely unknown. We describe an explant system in which exogenous recombinant N-Sonic Hedgehog (N-Shh) protein sustains the survival and proliferation of lung mesenchyme in a dose-dependent manner. In addition, Shh upregulates several mesenchymal cell markers, including its target gene Patched (Ptc), intercellular signaling genes Bone Morphogenetic and Noggin (Nog), and smooth muscle actin and myosin. In explants exposed to N-Shh in the medium, these products are upregulated throughout the mesenchyme, but not in the periphery. This exclusion zone correlates with the presence of an overlying mesothelial layer, which, as in vivo, expresses Fibroblast Growth Factor 9 (Fgf9). Recombinant Fgf9 protein inhibits the differentiation response of the mesenchyme to N-Shh, but does not affect proliferation. We propose a model for how factors made by two epithelial cell populations, the inner endoderm and the outer jacket of mesothelium, coordinately regulate the proliferation and differentiation of the lung mesoderm.
Introduction
Reciprocal epithelial-mesenchymal interactions are essential for the growth, differentiation, and patterning of many vertebrate organs. One of these is the embryonic mouse lung, which has proved a valuable model system for studying the molecular basis of signaling between embryonic tissue layers. The lung arises from the ventral foregut at embryonic day 10 (E10) as two primary buds, each consisting of three cell layers: the inner epithelium (of endodermal origin), the surrounding mesenchymal stroma, and a thin outer mesothelium. Early in development, the epithelium undergoes a stereotypic pattern of branching morphogenesis that is dependent on signals from the mesenchyme. Considerable work has focused on the molecular mechanisms controlling this branching and the proximaldistal differentiation of the respiratory epithelium (reviewed in Cardoso, 2001; Hogan et al., 1997) . By contrast, relatively little is known about tissue interactions regulating the development of the mesenchyme.
The cellular composition of the mesenchyme is complex and involves the distinct patterning of different cell types. One of the most obvious patterns is seen in smooth muscle, the development of which is temporally and spatially coordinated with that of the respiratory epithelium. At the level of the main bronchi, smooth muscle overlies the dorsal surface of the endoderm, while cartilaginous rings partially encompass the ventral airways. In all successive proximal airways, smooth muscle cells encircle the entire endoderm, but are characteristically absent from the advancing tips of distal airways during branching morphogenesis (Tollet et al., 2001) . In addition to smooth muscle and cartilage, there is evidence that early distal mesenchyme gives rise to endothelial cells of blood vessels and pericytes by the process of vasculogenesis (deMello et al., 1997; Partanen et al., 1996) and to artery-associated smooth muscle (Hall et al., 2000) . Postnally, the distal mesoderm generates myofibroblasts in the tips of the alveolar septae (Bostrom et al., 1996; Kapanchi, 1997) . Additional cell types found in the lung include stromal fibroblasts, interstitial lipofibroblasts (McGowan and Torday, 1997) , and lymphatic vessels.
Insight into lung mesenchyme development comes from both cellular and genetic studies. Lung mesenchyme cultured in vitro in the absence of endoderm fails to undergo either morphogenesis or differentiation, even in the presence of 10% serum (Gebb and Shannon, 2000; Taderera, 1967) . This suggests that the endoderm normally releases components required by lung mesenchyme, and several lines of genetic evidence point to Sonic hedgehog (N-Shh) as one factor involved. First, Shh is expressed in lung endoderm from the earliest stages of development, and protein is detected in respiratory epithelial cells from E10.5 until birth Bitgood and McMahon, 1995; Miller et al., 2001) . The gene encoding its receptor and downstream target, Ptc, is also transcribed in a dynamic pattern in the lung mesenchyme Motoyama et al., 1998; this paper) . Second, Shh homozygous null mutant mice have severely hypoplastic lungs; proliferation of the mesenchyme is reduced, and parabronchial smooth muscle differentiation is absent (Litingtung et al., 1998; Pepicelli et al., 1998) . Third, transgenic overexpression of Shh in the endoderm leads to increased amounts of highly proliferative mesoderm . Finally, all three Gli genes (Gli1, Gli2, and Gli3) encoding downstream intracellular regulators of Shh signaling are expressed in overlapping domains in the mesoderm Hui et al., 1994; Platt et al., 1997) . Embryos lacking combinations of Gli genes exhibit a spectrum of lung defects, ranging from abnormally shaped and fused lobes to complete absence of lung buds in Gli2 Ϫ/Ϫ ; Gli3 Ϫ/Ϫ compound mutants Motoyama et al., 1998; Park et al., 2000) . Taken together, these phenotypes suggest that the Shh signaling pathway has multiple roles in mesenchymal cell proliferation, differentiation, and patterning.
There is evidence that another cell layer, the outer mesothelium, is also essential for lung mesenchymal development. Mutation of Fibroblast growth factor 9 (Fgf9), expressed at high levels in the mesothelium, results in a decrease in stromal proliferation. Although the lung epithelium differentiates normally and the pulmonary vasculature is present, this loss of mesenchymal mass results in a smaller lung, with fewer generations of epithelial branches (Colvin et al., 1999 (Colvin et al., , 2001 ). However, the precise mechanisms by which Fgf9 affects lung mesenchyme development remain largely unexplored.
Here, we have developed an explant system to examine the mechanisms controlling lung mesoderm survival, differentiation, and patterning. We show that N-Shh promotes mesenchymal cell proliferation, the expression of genes encoding several intercellular signaling factors, and the dif- ferentiation of smooth muscle. By contrast, we demonstrate that Fgf9 produced by the mesothelium inhibits the upregulation of signaling factors and the differentiation of smooth muscle in response to Shh. Taken together, the results suggest a model for how the endoderm and the mesothelium cooperate in vivo to regulate the development of the intervening mesoderm. , and Flk1 lacZ have been described (Lawson et al., 1999; McMahon et al., 1998; Shalaby et al., 1995) . Nog lacZ homozygotes were obtained by intercrossing.
Materials and methods

Embryos and mouse strains
Mesenchyme and endoderm isolation
E11.5 embryos (noon on the day of vaginal plug is E0.5) heterozygous for the lacZ reporter allele were genotyped by staining hindlimbs for ␤-galactosidase activity. Lungs were washed two times in Tyrode-Ringer's solution and incubated in pancreatin-trypsin solution (Hogan et al., 1994) for 7-9 min on ice. Mesenchyme and endoderm were then separated by using tungsten needles in DMEM with 5% fetal bovine serum. Tightly adherent mesothelium was not specifically removed during dissection although its disruption was inevitable.
Tissue recombinations and mesenchyme explants
Each explant consisted of the total mesenchyme distal to the primary bronchi from one E11.5 lung, cultured on an 8-m Nucleopore track-etch filter (Whatman #110414, Clifton, NJ) floating on Schuger's mesenchyme culture medium (Yang et al., 1998) . This is Minimal Essential Medium (MEM) (Mediatech, VA) containing nonessential amino acids, 100 U/ml penicillin, 100 g/ml streptomycin, 0.29 mg/ml L-glutamine, and 10% fetal bovine serum (Summit Biotechnology, Fort Collins, CO). In some cases, a single whole lobe (mesenchyme ϩ endoderm) was cultured as a control. Cultures were incubated in 95% air/5% CO 2 at 37°C for a total of 72 h and fixed for 5 min in 4% paraformaldehyde in PBS at 4°C before X-gal staining and further processing.
For recombinations, mesenchyme from single heterozygous Nog lacZ /ϩ lungs was collected and cultured as above. After 24 h, freshly isolated E11.5 wildtype endoderm was placed adjacent to the mesenchyme and cultured for an additional 48 h.
Varying concentrations of recombinant, octyl modified N-Shh (a generous gift of Curis, Inc., Cambridge, MA) were added at the start of culture, either to the medium or loaded on beads. Fgf-loaded beads were added 24 h after the start of culture.
To determine cell numbers, explants were incubated on ice for 15 min in Tyrode-Ringer's solution (Hogan et al., 1994) , then for 15 min in 0.25% trypsin-EDTA (Gibco-BRL) at 37°C. After adding an equal volume of Shuger's medium, a single cell suspension was obtained by gentle agitation and cells counted using a hemocytometer. Mean differences between the log numbers of cells/ml in treatments were examined by an analysis of variance procedure, and additionally, an adjustment for multiple comparisons was applied. The results were still statistically significant after adjustment using the Tukey multiple comparisons procedure. This analysis was performed by using the SAS (SAS Inc., Cary, NC) system, version 8.1.
For cell proliferation assays, 5-bromo-2Ј-deoxyuridine and 5-fluoro-2Ј-deoxyuridine (Amersham, Buckingshire, England) was added at a 1:1000 dilution after 64 h. Explants were rinsed and fixed after 72 h of culture, and labeled cells were detected with the Cell Proliferation Kit (Amersham), except using fluorescent conjugated secondary antibodies (see below).
Preparation of protein loaded beads
For delivery of Fgf, acrylic beads with immobilized heparin (Sigma H-5263) were rinsed with PBS three times.
Beads of approximately 125-175 m in diameter were placed in siliconized tubes (25 beads/tube) and rotated in 25 ng/l recombinant human Fgf9 (R&D Systems, Minneapolis, MN), 50 ng/l recombinant human Fgf10 (generous gift of Dr. Nobuyuki Itoh, or purchased from R&D Systems), or 0.1% BSA for 30 min at 37°C, as described (Kettunen and Thesleff, 1998) , and subsequently washed extensively in MEM. Activity of Fgf10 was confirmed by using an endoderm migration assay (Weaver et al., 2000) .
For delivery of Shh, Affi-gel Blue Gel beads (100 -200 mesh) (Bio-Rad #153-7302, Hercules, CA) were washed and sorted as above and incubated in recombinant, octyl N-Shh (3 or 1 g/l) (gift of Curis, Inc.), or 0.1% BSA for 1 h at 37°C.
LacZ activity
Tissues fixed in 4% paraformaldehyde were incubated in X-gal substrate solution (Hogan et al., 1994) for 14 h at 37°C. After washing and postfixation, samples were dehydrated in an isopropanol series, embedded in paraffin, and sectioned at 7 m. Histoclear (National Diagnostics, Atlanta, GA) was used for embedding and dewaxing.
Immunohistochemistry
Immunohistochemistry was performed on paraffin-embedded sections of intact lungs or explants fixed in 4% paraformaldehyde. Some of these samples were previously stained for lacZ activity as above. Immunohistochemical reactions were carried out in parallel with control reactions lacking primary antibodies.
Immunofluorescence
Primary antibodies used include: mouse monoclonal anti-␣ smooth muscle actin (sma) (clone 1A4) (Sigma, St. Louis, MO), at 1:200 or 1:400 dilution and incubated at room temperature for 1 h; rabbit polyclonal anti-smooth muscle myosin (Biomedical Technologies, Inc., Stoughton, MA) at 1:100 dilution after antigen retrieval with 20 g/ml proteinase K at room temperature for 5 min; rabbit polyclonal anti-phospho-Histone H3 (Upstate Biotechnology, Lake Placid, NY) at 1:1000 dilution incubated at room temperature overnight after microwave antigen retrieval with 10 mM sodium citrate; polyclonal rabbit anti-human pan cytokeratin (Dako, Carpinteria, CA) at 1:500 dilution after proteinase K treatment as above. With the exception of sma, primary antibodies were incubated at 4°C overnight. Cy2 and Cy3 fluorescent conjugated antibodies from Jackson ImmunoResearch (West Grove, PA) were used according to the manufacturer's instructions. Secondary incubations were at room temperature for 1 h. Tissue was counterstained in 0.1 g/ml DAPI at room temperature for 5 min.
Immunochromagen
Immunostaining for Pecam/CD31 on paraformaldehydefixed, paraffin-embedded sections was performed essentially as described (Kalinichenko et al., 2001a) . Briefly, slides were treated with 1% trypsin in PBS for 5 min at 37°C to retrieve antigen, then incubated with rat monoclonal anti-pecam antibody (clone MEC13.3) (BD PharMingen, #550274) at a 1:50 dilution overnight at 4°C. Secondary antibody was biotinylated donkey anti-rat (Jackson ImmunoResearch) at 1:200 dilution for 1 h at room temperature. Signal was amplified by using streptavidin-horseradish peroxidase conjugate (Vectastain Elite ABC Kit; Vector, Burlingame, CA) and visualized with 3,3Ј-diaminobenzidine substrate (Vector). Tissues were counterstained with eosin.
Radioactive in situ hybridization
35 S-labeled anti-sense and sense riboprobes were prepared by using the Boehringer Mannheim RNA labeling kit and 850-bp Fgf9 (Colvin et al., 1999) and 841-bp Ptc (Platt et al., 1997) cDNA templates. All probes were hybridized in 50% formamide hybridization mix (Hogan et al., 1994) , except those for Fgf9, which were hybridized in 55% formamide to decrease background. Slides were exposed to emulsion for 2 (Ptc) or 4 (Fgf9) days and counterstained with hematoxylin. Twenty-four-hour fixation of explants was required for detection of Fgf9 in the mesothelium.
Scanning electron microscopy
Explants cultured for 72 h were fixed in 2% glutaraldehyde in phosphate buffer. Controls were accessory lobes from lungs exposed to the same conditions as explants, including pancreatin-trypsin treatment. Samples were rinsed for 5 min in PBS, pH 7.4, after which they were postfixed in 1% buffered osmium tetroxide for 30 min, rinsed with distilled water, and dehydrated in a graded series of ethanol. The samples were dried in a Balzer 020 critical point drying unit by using bone dry CO 2 . After mounting on aluminum stubs and gold coating in a Pelco SC-6 sputter coater, samples were viewed in a Hitachi s-2700 scanning electron microscope. Images were acquired digitally by using the Hitachi Quartz PCI imaging system.
Results
Temporal and spatial patterns of expression of Nog lacZ , Bmp4 lacZ , and Ptc in lung mesenchyme
As a prerequisite to the analysis of lung mesenchyme development, we first established the precise spatial patterns of expression of several important signaling genes transcribed in this tissue, including Bmp4 lacZ , Nog lacZ , and Ptc (Bellusci et al., 1996; Brunet et al., 1998; Lawson et al., 1999; McMahon et al., 1998; Weaver et al., 1999) . As shown in Figs. 1 and 2, Bmp4 lacZ and Nog lacZ are active in overlapping but not identical domains of lung mesoderm. At E11.5, Bmp4 lacZ activity is seen in a wide swath of cells, with highest levels adjacent to the proximal epithelium and lower levels toward the periphery (Fig. 1A-D) . At the same stage, strong Nog lacZ expression is restricted to one or two cell layers immediately adjacent to the proximal epithelium ( Fig. 1E-G) . In addition, Nog lacZ -positive cells are scattered throughout most of the distal mesoderm; these cells appear to express low levels of Nog, since their visualization requires long periods of staining and the Xgal product is punctate ( Fig. 1H ; see also Fig. 2C , E, and J). These overall expression patterns are maintained at E13.5 (Fig. 1I-N) , and Nog-positive cells are also visible at this time in the developing cartilage rings around the trachea and primary bronchi (Fig.  1M) .
The location of Nog lacZ -positive cells adjacent to the proximal endoderm suggested that they are parabronchial smooth muscle (Tollet et al., 2001 ). This hypothesis was confirmed by colocalization in tissue sections of high levels of ␤-galactosidase activity and sma in these cells, at all stages examined (E11.5, E13.5, E14.5, E15.5) (Fig. 2C-H , and data not shown). By contrast, Nog lacZ is neither expressed in perivascular smooth muscle (pericytes) associated with blood vessels and capillary beds, nor in the Pecam-expressing endothelial cells themselves (Fig. 2G-J) .
The domain of Bmp4 lacZ expression includes sma-positive cells adjacent to the endoderm, but also extends beyond it ( Fig. 2A and B) . Differentiated parabronchial smooth muscle therefore coexpresses Bmp4 lacZ and Nog lacZ , at least during the pseudoglandular stage of lung development. Given the high expression of Nog lacZ in parabronchial smooth muscle, we examined the phenotype of these cells in Nog homozygous null embryos. All the lungs of these embryos examined (n ϭ 30) exhibited abnormal gross morphology with malformed and truncated lobes (Fig. 3A and B, E and F). Seventy-eight percent (22/28) had fusions of the right lobes, with varying degrees of severity (data not shown), while 31% (9/29) had a blind-ended ectopic bud or diverticulum emerging near the junction of the main bronchi ( Fig. 3F and G) . However, smooth muscle actin and myosin immunostaining ( Fig.  3C and D, G and H) and transmission electron microscopy (data not shown) did not detect abnormalities in the smooth muscle cells associated with proximal airways.
It has been reported by several groups that Ptc, which encodes both a receptor for Shh and a transcriptional target of Shh signaling, is transcribed at high levels in the distal lung mesenchyme Litingtung et al., 1998; Motoyama et al., 1998; Pepicelli et al., 1998) . These studies had reported expression at E11.5 but had not examined later stages. Our data (Fig. 4) confirm the high levels of Ptc transcript in distal mesenchyme at E11.5 and show that they are maintained at E12.5 and E13.5 (Fig. 4A-F) . In addition, however, lower levels of Ptc transcript are evident surrounding more proximal airways at both later stages. For example, at E12.5, strong Ptc signal is detected around proximal airways and the main bronchi (Fig. 4D, white arrows) , while low levels can also be detected along the main bronchus at E13.5 (Fig. 4F , white arrows). Thus, cells throughout the lung mesenchyme, including putative smooth muscle cells around more proximal airways, may be responding to Shh signal in vivo.
Endoderm is required for mesenchymal cell proliferation and Noggin and Bmp4 expression in vitro
Previous studies determined that endoderm of E11.5 lungs produces factors required for the morphogenesis and differentiation of the mesenchyme (Gebb and Shannon, 2000; Taderera, 1967) . We confirmed this by culturing isolated distal endoderm and mesoderm in the presence of 10% serum (Fig. 5) . Under these conditions, mesenchyme alone spreads as a thin layer over the filter (Fig. 5A-C) , and the cells express neither Nog lacZ (n ϭ 10) (Figs. 5D and 6A) nor Bmp4 lacZ (n ϭ 14) (Fig. 6E ) after 72 h of culture. Since mesenchyme initially expresses both of these reporters (Fig.  1) , this loss of expression is due to either death of the expressing cells or shutoff of gene transcription. If wildtype (ϩ/ϩ) endoderm is added after 24 h, the endoderm and mesenchyme reassociate and the endoderm branches within the mesenchyme (Fig. 5F and G) . Moreover, the mesenchymal cells immediately adjacent to the endoderm express Nog lacZ , presumably in smooth muscle cells ( Fig. 5H ; n ϭ 3/4 lacZ-positive at 48 h; n ϭ 12/12 lacZ-positive at 72 h). The lacZ activity in these cells verifies that they are derived from the cultured mesenchyme and not from any wildtype mesenchyme carried over with the endoderm. As a control, whole accessory lobes from Nog lacZ ϩ/Ϫ lungs consistently express localized Nog lacZ at both 48 h (n ϭ 5/5) and 72 h (n ϭ 13/13) (data not shown). These results confirm that lung endoderm can maintain the survival of the mesenchyme and further suggest that factor(s) from the endoderm either induce Nog lacZ expression, or promote the survival of Nog lacZ -expressing cells, or both.
Proliferation in response to Shh
We next asked whether recombinant N-Shh protein can substitute for endoderm in the explant system. Explants exposed to increasing doses of Shh are shown in Fig. 6A-D . If Shh is added to the culture medium at 300 ng/ml (n ϭ 12), 1 g/ml (n ϭ 3), and 3 g/ml (n ϭ 44), the number of cells increases in a dose-dependent manner compared with controls. Before culture, mesenchyme explants contain, on av- erage, 3.7 ϫ 10 5 cells/ml (Ϯ9.8 ϫ 10 4 , n ϭ 6). By 72 h in the absence of Shh, the cell number declines eightfold, to 4.6 ϫ 10 4 /ml (Ϯ2.2 ϫ 10 4 , n ϭ 6). In contrast, with addition of 300 ng/ml Shh, the average number of cells increases threefold to 1.2 ϫ 10 6 /ml (Ϯ1.8 ϫ 10 5 , n ϭ 6). With 3 g/ml Shh treatment, an almost ninefold increase is seen, with 3.3 ϫ 10 6 cells/ml (Ϯ3.8 ϫ 10 5 , n ϭ 6). These numbers are significantly different (P Ͻ 0.0001; see Materials and methods). Labeling of cultures with BrdU or Phospho-histone H3, a marker of cells in mitosis, shows that proliferating cells are present throughout the explants, including the outer layer and periphery ( Fig. 6I ; see Fig. 9G and H). Based on these findings, subsequent experiments were carried out with 3 g/ml Shh in the medium.
Gene expression and cell differentiation in response to Shh
To further assess the response of lung mesenchyme to Shh, we examined gene expression and cellular differentiation. Cultures exposed to 3 g/ml Shh show high but nonuniform expression of Ptc (n ϭ 4), Nog lacZ (n ϭ 24), and Bmp4 lacZ (n ϭ 7) throughout the explant (Fig. 6F-H) .
The increase in Nog lacZ expression was dose-dependent with increasing concentrations of Shh treatment (Fig.  6B-D) .
It has been reported that Shh indirectly promotes angiogenesis of blood vessels in vivo (Pola et al., 2001 ). We therefore examined the effect of N-Shh on the expression of (Fig. 6H) . Again, the extent of the staining is dose-dependent, with increasing numbers of Flk lacZ -positive cells observed with increasing concentrations of Shh (data not shown).
Finally, we asked whether the expression of smooth muscle markers is affected by exogenous Shh. As shown in Fig. 7 , in the presence of 3 g/ml Shh, there is strong immunolocalization of both sma and smooth muscle myosin (smm) throughout explants, in a nonuniform pattern. In some regions, there is coincidence between the high Nog lacZ and high sma expression; but in other areas, cells that express high levels of Nog lacZ apparently stain only weakly for sma, and vice versa (compare Fig. 7A and B) . This is also the case in vivo, where only a subset of smooth musclepositive cells also expresses Nog lacZ (see Fig. 2 ). 
Lung mesenchyme explants are covered by mesothelium
In mesenchyme explants, we consistently observed zones about five to eight cell diameters wide at the periphery that have low or no expression of Nog lacZ , Bmp4 lacZ , sma, and Flk1 lacZ ( Fig. 6F and H ; between black bars in Fig. 7A , C, and G and white bars in Fig. 7B and D) . We hypothesized that these nonexpressing regions are associated with the mesothelium, a squamous epithelium that covers the outer surface of the embryonic lung in vivo. We tested whether this layer is maintained in vitro using a pan-cytokeratin antibody that stains epithelial cells, including the lung mesothelium, but not mesenchyme. As shown in Fig. 7G and H, wherever mesothelial-like cells are detected in sections of Nog lacZ explants, they are underlain by a domain of low Nog lacZ activity.
To confirm the presence and integrity of mesothelial cells in the culture system, we compared the phenotype of cells on the outer surface of explants with that of normal lung mesothelium. First, histological analysis of sectioned explants shows that the outer cells have a thin, squamous morphology, similar to that of cells covering the E13.5 lung (Fig. 8A and B) , and very different from that of the endodermal epithelium, which is cubical or columnar (asterisk, Fig.  8A ). This similarity extends to the scanning electron microscope level, where cells on the surface of both explants and normal E11.5 accessory lobes exhibit the characteristic shape and surface microvilli of mesothelial cells (Mutsaers, 2002) (Fig. 8C and D) . Finally, cells on the outer surface of explants, like the mesothelium of the normal embryonic lung, express Fgf9 ( Fig. 8E-H; and Colvin et al., 1999) .
Fgf9 influences mesenchyme differentiation
Our results suggest that factors released by the mesothelium of explants influence the differentiation of underlying mesenchymal cells. One candidate for mediating this effect, both in vivo and in vitro, is Fgf9. Two potential receptors for this protein, FgfR1IIIc and FgfR2IIIc, are expressed in lung mesenchyme (Cardoso et al., 1997; Colvin et al., 2001; Orr-Urtreger et al., 1993; Peters et al., 1992) . We tested this hypothesis by implanting Fgf9-loaded beads into explants that had been cultured in 3 g/ml N-Shh for 24 h. Under these conditions, Nog lacZ expression is inhibited around the bead (n ϭ 8/8) ( Fig. 9A and C) . By contrast, this inhibitory effect is not seen with beads loaded with either PBS (n ϭ 0/10) or Fgf10, a factor which signals through an alternative receptor to Fgf9 (n ϭ 0/7) ( Fig. 9B and D) . Fgf9-soaked beads also inhibit the differentiation of sma-positive cells (Fig. 9E, n ϭ 13) , an effect not seen with Fgf10 ( Fig. 9F ; n ϭ 7) or PBS beads (data not shown; n ϭ 3). BrdU incorporation studies did not detect any difference in cell proliferation levels surrounding beads loaded with either Fgf9 (Fig. 9G ; n ϭ 7) or Fgf10 ( Fig. 9H; n ϭ 4) . Rather, proliferation appears uniform throughout the explant.
Locally applied Shh upregulates Ptc and Bmp4 in lung mesenchyme explants
To test the local action of Shh, we applied N-Shh-loaded beads to mesenchyme explants. In these cases, the expression of both Ptc (Fig. 10A and B) and Bmp4 lacZ (n ϭ 13/15) ( Fig. 10E and G) is localized around the bead. However, proliferation occurs throughout the explant (Fig. 10C and  D) . Compared with Ptc and Bmp4 lacZ , a much less uniform distribution of Nog lacZ ( Fig. 10F and H ; n ϭ 9/9) and sma expression ( Fig. 10I and J) is seen relative to the Shh-loaded beads, and the two products do not always colocalize. The reason for this result is not clear, but suggests that some responses to a localized source of Shh are particularly sensitive to factors such as local cell density and uneven extracellular matrix accumulation.
Discussion
The patterning and differentiation of the mesenchyme in the developing lung is a largely unexplored area. Here, we have established an explant assay system in which N-Shh can substitute for some of the well-documented functions of the lung endoderm in supporting the survival, proliferation, and differentiation of the mesoderm (Gebb and Shannon, 2000; Taderera, 1967) (Fig. 5) . Using this assay, we can, for the first time, manipulate molecular factors in order to assess their direct effects on the mesenchyme. We find that recombinant N-Shh promotes both the proliferation of lung mesenchyme and the differentiation of smooth muscle. By contrast, signals from the mesothelium, particularly Fgf9, inhibit at least some of the effects of N-Shh on mesenchyme differentiation. We conclude that the endoderm and the mesothelium normally work together to regulate the size and fate of a pool of mesenchyme progenitor cells in the distal lung. In the future, modifications of the culture system, including the replacement of serum factors and the identification of cell-autonomous markers for multiple specific mesodermal cell types, will allow these regulatory mechanisms to be further explored.
Effect of Shh on lung mesenchyme differentiation
In vivo or in vitro, the expression of Nog lacZ and sma is tightly restricted to mesenchyme that is in close proximity with lung endoderm, a tissue producing N-Shh (Figs. 1, 2 , and 5). By contrast, exogenous N-Shh in the culture medium induces the expression of these markers throughout the mesenchyme, with the exception of a peripheral zone (discussed below). In this assay, the number of cells expressing markers for specific cell types (including Nog lacZ and sma) increases in a dose-dependent manner in response to recombinant protein, illustrating that more mesodermal cells have the potential to express these genes than normally do so in vivo. This suggests that Shh not only supports the survival and proliferation of preexisting cell types but also (directly or indirectly) promotes the differentiation of progenitor cells into specific lineages. Our bead studies further show that Ptc and Bmp4 lacZ are induced uniformly in the mesenchyme in response to a localized source of Shh (Fig.  10) . However, since markers of smooth muscle, such as Nog lacZ and sma, are not induced in a reproducible spatial pattern around the bead, differentiation must be influenced by other factors, such as local cell density and extracellular matrix accumulation (Yang et al., 1999; Zhang et al., 1999) . Alternatively, or in addition, Shh may indirectly induce these markers by affecting the expression of other signaling molecules. Among the other factors that have been implicated in promoting smooth muscle differentiation in the lung are members of the platelet-derived growth factor (Pdgf) and transforming growth factor ␤ (Tgf␤) families of signaling molecules (Bostrom et al., 1996; Bragg et al., 2001; Lindahl et al., 1999; Sun et al., 2000; Zhou et al., 1996) . 
Bmp4
lacZ is induced locally around a Shh-loaded bead (red circles), as viewed both in whole-mount (E) and section (G). Nog lacZ -positive cells are also observed, but are not exclusively localized around the bead in either whole mount (F) or section (H). Costaining of these sections for Sma Our results in culture provide evidence that Shh signaling over an extended period promotes the differentiation of lung mesenchyme into smooth muscle. This conclusion is compatible with genetic studies implicating Shh, and its downstream target Foxf1, in the differentiation of smooth muscle in the normal lung (Kalinichenko et al., 2001b; Lim et al., 2002; Mahlapuu et al., 2001; Pepicelli et al., 1998) . However, our results raise an apparent paradox: Shh is normally expressed throughout the lung endoderm, with highest levels in the distal tips, and Ptc transcription is also highest in the distal mesenchyme, compared with mesenchyme around the proximal endoderm (Fig. 4 ). Yet, smooth muscle cells are absent from these domains of distal mesoderm. This paradox may be explained by the rapid outgrowth of respiratory endoderm during lung development in vivo. After initial exposure to high levels of Shh at the endoderm tip, the mesenchymal cells may move proximally relative to the distal endoderm. This may be a passive translocation, driven by endoderm outgrowth, and/or involve active mesenchymal cell migration. By the time they are competent to differentiate into smooth muscle, the mesenchyme cells are thus localized around proximal endoderm (Fig. 11) . These models will be tested in the future by using lineage labeling techniques.
Endodermal and mesenchymal Bmp4 expression domains are differentially regulated
Our studies reveal differential regulation of Bmp4 in the endodermal and mesenchymal tissue layers of the lung. The explant experiments provide evidence that Shh, normally made by the endoderm, induces Bmp4 in lung mesenchyme, at least at early stages of development. This finding is in agreement with reports that Bmp4 transcripts are lost in Shh mutant lung mesenchyme (Litingtung et al., 1998) . Moreover, local induction of Bmp2/4 by Shh has been reported in several other organs, including the hindgut (Roberts et al., 1995; Sukegawa et al., 2000) , the pituitary (Treier et al., 2001) , and the kidney (Yu et al., 2002) . This contrasts with endodermal regulation of Bmp4 in the lung, which is controlled by localized Fgf signals, including Fgf10, in distal mesenchyme (Hyatt et al., 2002; Lebeche et al., 1999; Fig. 11 . "Sandwich" model for patterning of lung mesenchyme. Mesenchymal cells (circles) are sandwiched between the mesothelium (pink) and the endoderm (yellow). Signals from the mesothelium, such as Fgf9 (pink triangle), help to maintain peripheral cells in an undifferentiated or multipotent state. Shh made by the endoderm (yellow triangle) promotes cell survival/proliferation, and also induces differentiation. Factors made by the more proximal endoderm, including basal lamina proteins (black dotted line), promote terminal differentiation of parabronchial smooth muscle. Arrows indicate relative movement of mesenchyme (gray) and endoderm (yellow). Open circles, multipotent cells; green circles, Nog-expressing cells; blue circles, Bmp4-expressing cells; red circles, sma-positive cells. Cells can be positive for Nog, Bmp4, and sma, or any combination of these markers. Weaver et al., 2000) . Taken together, these results emphasize that the same gene, Bmp4, can be regulated by different signals in adjacent cell populations. It is also likely that there are stage-specific changes in the response of lung mesenchyme to Shh, since our previous studies of transgenic embryos overexpressing Shh in lung endoderm showed no change in the expression of Bmp4 in the lung at E18.5 .
Factors made by the mesothelium regulate mesenchyme differentiation
The mesothelium expresses high levels of Fgf9 from the early pseudoglandular stage, and Fgf9 Ϫ/Ϫ lungs are smaller than wild type (Colvin et al., 2001) . Despite extensive analysis, no missing cell types or other differentiation defects are detected in these lungs. It has therefore been suggested that Fgf9 from the mesothelium functions to maintain the proliferation of distal mesenchyme, including cells that express Fgf10 (Colvin et al., 2001) . Our data support this hypothesis and provide further novel evidence that Fgf9 counteracts factors, including Shh, that promote the differentiation of the mesenchyme. We hypothesize that mesenchymal progenitor cells in the periphery of the developing lung, exposed to high levels of Fgf9 and relatively low levels of Shh, are maintained in an undifferentiated state (Fig. 11) . However, we cannot rule out the possibility that Fgf9 promotes their differentiation into peripheral mesenchymal cell types for which we do not yet have markers. The differentiation state of the mesenchyme may be further modulated by other factors made by the mesothelium, such as Tgf␤3 (Bragg et al., 2001; Pelton et al., 1991) and retinoic acid (Malpel et al., 2000; Niederreither et al., 2002) .
Conclusion: "sandwich" model for the patterning of mesenchyme during early lung development
In summary, we propose the following model for lung mesenchyme development, as depicted in Fig. 11 :
In the early lung, mesenchyme is "sandwiched" between two distinct tissues: the endoderm and the mesothelium. From the interior of the lung, Shh produced by the endoderm promotes the proliferation of the mesenchyme, possibly by acting as a direct mitogen and modulating the levels of intracellular cyclins (Barnes et al., 2001; DumanScheel et al., 2002; Long et al., 2001) . In addition, Shh may have roles in controlling cell fate and cell differentiation. However, whether it acts directly as a morphogen, as in the vertebrate neural tube (for review, see Marti and Bovolenta, 2002) , or indirectly by inducing mesenchymal factors such as Bmp4, remains an open question. Toward the periphery, the cells come under the influence of the mesothelium, which inhibits stromal cell differentiation and thereby helps to maintain a local population of multipotent progenitor cells. Fgf9 plays an important role in this process. Future studies will be directed at identifying molecular markers for mesenchymal progenitor populations and at clarifying how signals from both the endoderm and mesothelium regulate differentiation and patterning.
